Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TURKOVAC in healthy pregnant women
NCT06997653Phase 2Withdrawn
- Sponsor
- TÜSEB
- Start
- Jan 2024
- Primary completion
- Jan 2024
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of turkovac in coronavirus disease 2019 (COVID-19), sponsored by TÜSEB. Planned start Jan 2024; status: withdrawn.
02
Drugs
turkovac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06997653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06997653.